Search clinical trials for: LB1148

Total 9 results

Palisade Bio

Recruiting

A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection (PROFILE)

Ileus | Post-Operative Adhesions

United States
Newsoara Biopharma Co., Ltd.

Completed

Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus

Ileus

China
Palisade Bio

Active, not recruiting

A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection (INTEGRITY)

Ileus | Gastro-Intestinal Disorder

United States
Legend Biotech USA Inc

Recruiting

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Gastroesophageal-junction Cancer

United States
Ronald Hurst, MD, FACS

Completed

A Study to Evaluate the Safety, Tolerability and Efficacy of LB1148 for Subjects Undergoing Elective Bowel Resection

Ileus | Adhesions

United States
L & L biopharma Co., Ltd., Shanghai China

Recruiting

A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001）

Lymphoma | Solid Tumor

China
Leading BioSciences, Inc

Terminated

Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL)

Septic Shock

United States, Canada
Leading BioSciences, Inc

Withdrawn

LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia

COVID-19 | Covid19 | Coronavirus Disease 2019 | COVID-19 Pneumonia
Lipocine Inc.

Completed

A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia

Liver Cirrhosis | Sarcopenia

United States

3

Subscribe